Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Biomunex Pharmaceuticals SASU

Biomunex is a biopharmaceutical company focused on providing immuno-therapeutics through the discovery and development of bi- and multi-specific antibodies, created from its next generation proprietary BiXAb® platform. Its most advanced candidate has demonstrated superior in vitro and in vivo efficacy and could become a highly potent immunotherapy for several solid tumors, such as head-and-neck, gastric and pancreatic cancers. Its other lead candidate, which leverages the power of immune checkpoint inhibition, is being evaluated for hematological malignancies and is showing a high therapeutic potential. In collaboration with renowned public institutions in Europe, Biomunex has also initiated the discovery and development of several additional cutting-edge multi-specific antibodies, which will employ novel approaches. *

 

Period Start 2014-03-04 established
Products Industry BiXAb® technology (for bi- and multi-specific antibodies)
  Industry 2 BMX-002 (Biomunex)
Persons Person Gerard, Pierre-Emmanuel (Biomunex 2014– CEO + Co-Founder)
  Person 2 Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor)
     
Region Region Paris
  Country France
  Street 14 avenue d’Eylau
  City 75116 Paris
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Biomunex Pharmaceuticals SASU. (1/15/19). "Press Release: Biomunex Pharmaceuticals Signs a Licensing Agreement with Sanofi for the Development of Bi- and Multi-specific Antibodies". Paris.
     
   
Record changed: 2021-02-17

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Biomunex Pharmaceuticals SASU


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top